Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $597.19 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $315.98 | 17 | $0 (2019) |
| Allergan Inc. | $122.83 | 4 | $0 (2017) |
| Novo Nordisk Inc | $52.33 | 3 | $0 (2020) |
| PFIZER INC. | $37.06 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $34.27 | 2 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $20.86 | 1 | $0 (2018) |
| Lilly USA, LLC | $13.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $17.12 | 1 | Janssen Pharmaceuticals, Inc ($17.12) |
| 2020 | $35.85 | 2 | Novo Nordisk Inc ($18.70) |
| 2019 | $78.37 | 4 | AstraZeneca Pharmaceuticals LP ($78.37) |
| 2018 | $153.22 | 8 | AstraZeneca Pharmaceuticals LP ($77.06) |
| 2017 | $312.63 | 15 | AstraZeneca Pharmaceuticals LP ($160.55) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 07/11/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Respiratory | ||||||
| 03/26/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2018 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/03/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 05/09/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: pseudobulbar affect PBA | ||||||
| 04/30/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/23/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Respiratory | ||||||
| 03/01/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Respiratory | ||||||
| 11/08/2017 | Allergan Inc. | NAMENDA XR (Drug), NAMZARIC | Food and Beverage | In-kind items and services | $68.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Respiratory | ||||||
| 08/22/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Respiratory | ||||||
| 06/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Respiratory | ||||||
| 05/10/2017 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 67 | 107 | $19,413 | $7,725 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 44 | $10,296 | $3,865 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 34 | $5,406 | $2,065 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $3,048 | $1,471 | 48.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 17 | 17 | $663.00 | $323.86 | 48.8% |
About Dr. Jesus Menendez Rivera, M.D
Dr. Jesus Menendez Rivera, M.D is a General Practice healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013978816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesus Menendez Rivera, M.D has received a total of $597.19 in payments from pharmaceutical and medical device companies, with $17.12 received in 2021. These payments were reported across 30 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($597.19).
As a Medicare-enrolled provider, Menendez Rivera has provided services to 67 Medicare beneficiaries, totaling 107 services with total Medicare billing of $7,725. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Miami, FL
- Active Since 03/31/2006
- Last Updated 04/16/2025
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013978816
Products in Payments
- FARXIGA (Drug) $183.75
- SYMBICORT (Drug) $132.23
- NAMENDA XR (Drug) $68.26
- VRAYLAR (Drug) $36.38
- XARELTO (Drug) $34.27
- Victoza (Drug) $33.63
- CHANTIX (Drug) $22.02
- NUEDEXTA (Drug) $20.86
- Ozempic (Drug) $18.70
- NAMZARIC (Drug) $18.19
- LYRICA (Drug) $15.04
- TRULICITY (Drug) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Miami
Dr. Rafael Gonzalez, M.d, M.D
General Practice — Payments: $727,118
Dr. Jose Cardona, M.d, M.D
General Practice — Payments: $177,395
Idalia Acosta, M.d, M.D
General Practice — Payments: $132,449
Omar Benitez, Md, MD
General Practice — Payments: $123,017
Dr. Orlando Rivero, Md, MD
General Practice — Payments: $116,765
Lilia Rodriguez Ables, Md, MD
General Practice — Payments: $100,020